Recruiting PHASE4 INTERVENTIONAL 1-arm
NCT06520410
Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Sponsor: Chang Gung Memorial Hospital
Conditions
Coats Disease Coats Retinopathy Familial Exudative Vitreoretinopathies Persistent Fetal Vasculature Retinal Disease Retinal Vascular Disorder Retinopathy of Prematurity Both Eyes Vitreous Anomalies Vitreous Disorder
Interventions
Pars plana vitrectomy with a 18 mm short vitrector
Updated 3 times since 2024 Last updated: Jul 21, 2024 Started: Mar 5, 2024 Primary completion: Feb 28, 2026 Completion: Feb 28, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Coats Disease and Coats Retinopathy and is currently actively recruiting participants. Chang Gung Memorial Hospital leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE4
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Chang Gung Memorial Hospital
Data source: Chang Gung Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .